Potential of Plant-Derived Compounds in Preventing and Reversing Organ Fibrosis and the Underlying Mechanisms
Cells · 28.02.2024 · 13 (5) · 421
DOI: 10.3390/cells13050421 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 28.02.2024. Verfasst von Patrícia Dos Santos Azeredo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Atherosclerosis, Thrombosis and Cell Therapy, Institute of Biology, State University of Campinas-UNICAMP Campinas, Campinas 13083-970, …. Hauptthemen laut MEDLINE: Extracellular Matrix, Phytochemicals. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 210 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAAA NIH HHS, NIH HHS, National Institutes of Health (National Institute on Alcohol Abuse and Alcoholism).
Abstract (Originalsprache)
Increased production of extracellular matrix is a necessary response to tissue damage and stress. In a normal healing process, the increase in extracellular matrix is transient. In some instances; however, the increase in extracellular matrix can persist as fibrosis, leading to deleterious alterations in organ structure, biomechanical properties, and function. Indeed, fibrosis is now appreciated to be an important cause of mortality and morbidity. Extensive research has illustrated that fibrosis can be slowed, arrested or even reversed; however, few drugs have been approved specifically for anti-fibrotic treatment. This is in part due to the complex pathways responsible for fibrogenesis and the undesirable side effects of drugs targeting these pathways. Natural products have been utilized for thousands of years as a major component of traditional medicine and currently account for almost one-third of drugs used clinically worldwide. A variety of plant-derived compounds have been demonstrated to have preventative or even reversal effects on fibrosis. This review will discuss the effects and the underlying mechanisms of some of the major plant-derived compounds that have been identified to impact fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Atherosclerosis, Thrombosis and Cell Therapy, Institute of Biology, State University of Campinas-UNICAMP Campinas, Campinas 13083-970, Brazil.
- Department of Cell Biology and Anatomy, School of Medicine, University of South Carolina, Columbia, SC 29209, USA.
- Department of Pathology, Microbiology and Immunology, School of Medicine, University of South Carolina, Columbia, SC 29209, USA.
ORCID-Profile: Patrícia Dos Santos Azeredo
Förderung
- NIAAA NIH HHS
- NIH HHS
- National Institutes of Health (National Institute on Alcohol Abuse and Alcoholism)
Zitieren
APA
Azeredo, P. D. S., Fan, D., Murphy, E. A., & Carver, W. E. (2024). Potential of Plant-Derived Compounds in Preventing and Reversing Organ Fibrosis and the Underlying Mechanisms. Cells, 13(5), 421. https://doi.org/10.3390/cells13050421
Vancouver
Azeredo PDS, Fan D, Murphy EA, Carver WE. Potential of Plant-Derived Compounds in Preventing and Reversing Organ Fibrosis and the Underlying Mechanisms. Cells. 2024;13(5):421. doi:10.3390/cells13050421
BibTeX
@article{Azeredo2024,
author = {Azeredo, Patrícia Dos Santos and Fan, Daping and Murphy, E Angela and Carver, Wayne E},
title = {Potential of Plant-Derived Compounds in Preventing and Reversing Organ Fibrosis and the Underlying Mechanisms},
journal = {Cells},
year = {2024},
volume = {13},
number = {5},
pages = {421},
doi = {10.3390/cells13050421}
}
EUVIMED